
Anne Freier

Organovo Gets Orphan Drug Designation for 3D Printed Liver Tissue | All3DP
The designation offers several benefits for Organovo, but more importantly, brings a potentially useful solution for alpha-1 antitrypsin deficiency to market. Organovo Holdings Ltd., the company that designs and creates 3D human tissues for drug discovery and clinical trials, has recently been granted orphan drug designation by the US Food and Drug Administration (FDA). Orphan […]